---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024286"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2023-07-12T23:59:59+00:00"
generated_at: "2026-06-13T09:36:38.189913+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Biofrontera appoints Dr. Heikki Lanckriet to Board under settlement with major stockholder

## Summary
- Dr. Heikki Lanckriet appointed to Board of Directors effective July 7, 2023 as Class I director through 2025 annual meeting.
- Nominated by Biofrontera AG under April 2023 settlement agreement between the companies.
- Compensation: $40,250 annual retainer (pro-rated for 2023) plus annual stock award.
- Lanckriet serves as CEO/CSO of 4basebio PLC and on Biofrontera AG's Supervisory Board.

## SEC filing metadata
- accession: 0001493152-23-024286
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2023-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/0001493152-23-024286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024286
- JSON: https://secwatch.observer/filing/0001493152-23-024286.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024286.txt

## Key facts
- Executive change
  Heikki Lanckriet was appointed as Director at Biofrontera Inc..
  - Action: appointed
  - Role: Director
  source text: On July 7, 2023, the board of directors (the “Board”) of Biofrontera Inc. (the “Company”) appointed Heikki Lanckriet to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223024286/0001493152-23-024286-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.